Spots Global Cancer Trial Database for adenosine receptor modulator
Every month we try and update this database with for adenosine receptor modulator cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF -509 (80 mg, 160 mg and 240 mg) "After Multiple Oral Doses" in Healthy Volunteers | NCT02111330 | Parkinson Disea... | PBF-509 Placebo | 18 Years - 45 Years | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
